Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement
10 Gennaio 2025 - 7:24PM
Spartan Capital Securities, LLC, a premier investment banking
firm, is pleased to announce the successful completion of two
private placements for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO).
Spartan Capital Securities, LLC acted as the sole placement agent
in these private offerings of Series B non-voting convertible
preferred stock of Lipella Pharmaceuticals Inc., raising an
aggregate total of $875,500 through the transactions.
The private placements were successfully completed, subject to
customary closing conditions. The proceeds from these offerings
will support Lipella’s continued advancement of its clinical
pipeline and general corporate purposes.
Jonathan Kaufman, PhD, CEO of Lipella Pharmaceuticals, continues
to lead the company’s efforts to address significant unmet medical
needs with safe and effective therapies.
“We are proud to serve as the sole placement agent in these
private placements for Lipella Pharmaceuticals,” said John Lowry,
CEO of Spartan Capital Securities. “Lipella’s dedication to
developing innovative therapies aimed at improving patient outcomes
is inspiring. These successful transactions reflect both the
strength of Lipella’s clinical pipeline and Spartan Capital’s
commitment to facilitating impactful investment opportunities. We
look forward to supporting Lipella’s future growth and
success.”
Sichenzia Ross Ference Carmel LLP served as placement agent
counsel, while Sullivan & Worcester LLP acted as counsel to
Lipella Pharmaceuticals Inc.
Further details on the transactions will be available in the
Company’s Form 8-K, to be filed with the U.S. Securities and
Exchange Commission and accessible at www.sec.gov.
The common shares and the common shares issuable upon the
conversion of related warrants have not been registered under the
Securities Act of 1933, as amended, or any state securities laws.
Until registered, these securities may not be offered or sold in
the United States or any state absent registration or an applicable
exemption from registration requirements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of
these securities in any state or jurisdiction where such offer,
solicitation, or sale would be unlawful prior to registration or
qualification under applicable securities laws.
About Spartan Capital Securities, LLC
Spartan Capital Securities, LLC is a premier full-service
investment banking firm offering a comprehensive range of advisory
services to institutional clients and high-net-worth individuals.
Known for its expertise in capital raising, strategic advisory, and
asset management, Spartan Capital delivers tailored solutions to
meet clients' financial goals.
For more information about Spartan Capital Securities, visit
www.spartancapital.com.
Contact: Spartan Capital Securities, LLC45
Broadway, 19th FloorNew York, NY
10006investmentbanking@spartancapital.com
Grafico Azioni Lipella Pharmaceuticals (NASDAQ:LIPO)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Lipella Pharmaceuticals (NASDAQ:LIPO)
Storico
Da Gen 2024 a Gen 2025